{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:09:55Z","timestamp":1785161395409,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470748"],"award-info":[{"award-number":["81470748"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10753-018-0934-0","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T01:17:53Z","timestamp":1542849473000},"page":"799-810","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Expression of CXCL10\/CXCR3 and Effect of the Axis on the Function of T Lymphocyte Involved in Oral Lichen Planus"],"prefix":"10.1007","volume":"42","author":[{"given":"Jiaxiang","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,22]]},"reference":[{"issue":"8","key":"934_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1600-0714.2008.00662.x","volume":"37","author":"BE McCartan","year":"2008","unstructured":"McCartan, B.E., and C.M. Healy. 2008. The reported prevalence of oral lichen planus: A review and critique. Journal of Oral Pathology & Medicine 37 (8): 447\u2013453.","journal-title":"Journal of Oral Pathology & Medicine"},{"issue":"6","key":"934_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.oraloncology.2010.02.016","volume":"46","author":"I Waal van der","year":"2010","unstructured":"van der Waal, I. 2010. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncology 46 (6): 423\u2013425.","journal-title":"Oral Oncology"},{"issue":"2","key":"934_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.tripleo.2010.03.034","volume":"110","author":"Y Wu","year":"2010","unstructured":"Wu, Y., G. Zhou, H. Zeng, C.R. Xiong, M. Lin, and H.M. Zhou. 2010. A randomized double-blind, positive-control trial of topical thalidomide in erosive oral lichen planus. Oral Surgery Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 110 (2): 188\u2013195.","journal-title":"Oral Surgery Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics"},{"issue":"1","key":"934_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/08923973.2010.498014","volume":"33","author":"V Crincoli","year":"2011","unstructured":"Crincoli, V., M.B. Di Bisceglie, M. Scivetti, A. Lucchese, S. Tecco, and F. Festa. 2011. Oral lichen planus: Update on etiopathogenesis, diagnosis and treatment. Immunopharmacol Immunotoxicol 33 (1): 11\u201320.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"2","key":"934_CR5","first-page":"ZE10","volume":"10","author":"SS Suresh","year":"2016","unstructured":"Suresh, S.S., K. Chokshi, S. Desai, R. Malu, and A. Chokshi. 2016. Medical management of oral lichen planus: A systematic review. Journal of Clinical and Diagnostic Research 10 (2): ZE10\u2013ZE15.","journal-title":"Journal of Clinical and Diagnostic Research"},{"issue":"5","key":"934_CR6","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1007\/s10753-015-0167-4","volume":"38","author":"Y Wang","year":"2015","unstructured":"Wang, Y., J. Zhou, S. Fu, C. Wang, and B. Zhou. 2015. A study of association between oral lichen planus and immune balance of Th1\/Th2 cells. Inflammation 38 (5): 1874\u20131879.","journal-title":"Inflammation"},{"issue":"22","key":"934_CR7","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1158\/1078-0432.CCR-10-0712","volume":"16","author":"WY Peng","year":"2010","unstructured":"Peng, W.Y., Y. Ye, B.A. Rabinovich, C.W. Liu, Y.Y. Lou, M.Y. Zhang, M. Whittington, Y. Yang, W.W. Overwijk, G. Lizee, and P. Hwu. 2010. Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses. Clinical Cancer Research 16 (22): 5458\u20135468.","journal-title":"Clinical Cancer Research"},{"issue":"7","key":"934_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1042\/CS20150666","volume":"130","author":"R Altara","year":"2016","unstructured":"Altara, R., M. Manca, R.D. Brandao, A. Zeidan, G.W. Booz, and F.A. Zouein. 2016. Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases. Clinical Science (London, England) 130 (7): 463\u2013478.","journal-title":"Clinical Science (London, England)"},{"key":"934_CR9","first-page":"893106","volume":"2014","author":"P Borne van den","year":"2014","unstructured":"van den Borne, P., P.H. Quax, I.E. Hoefer, and G. Pasterkamp. 2014. The multifaceted functions of CXCL10 in cardiovascular disease. BioMed Research International 2014: 893106.","journal-title":"BioMed Research International"},{"issue":"3","key":"934_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cytogfr.2014.11.009","volume":"26","author":"K Raemdonck Van","year":"2015","unstructured":"Van Raemdonck, K., P.E. Van den Steen, S. Liekens, J. Van Damme, and S. Struyf. 2015. CXCR3 ligands in disease and therapy. Cytokine & Growth Factor Reviews 26 (3): 311\u2013327.","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"1","key":"934_CR11","first-page":"1","volume":"8","author":"A Andalib","year":"2011","unstructured":"Andalib, A., H. Doulabi, M. Najafi, M. Tazhibi, and A. Rezaie. 2011. Expression of chemokine receptors on Th1\/Th2 CD4+ lymphocytes in patients with multiple sclerosis. Iranian Journal of Immunology 8 (1): 1\u201310.","journal-title":"Iranian Journal of Immunology"},{"issue":"5","key":"934_CR12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1365-2990.2010.01089.x","volume":"36","author":"M Muller","year":"2010","unstructured":"Muller, M., S. Carter, M.J. Hofer, and I.L. Campbell. 2010. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity\u2014a tale of conflict and conundrum. Neuropathology and Applied Neurobiology 36 (5): 368\u2013387.","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"13","key":"934_CR13","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1128\/JVI.00202-11","volume":"85","author":"CP Marques","year":"2011","unstructured":"Marques, C.P., P. Kapil, D.R. Hinton, C. Hindinger, S.L. Nutt, R.M. Ransohoff, T.W. Phares, S.A. Stohlman, and C.C. Bergmann. 2011. CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis. Journal of Virology 85 (13): 6136\u20136147.","journal-title":"Journal of Virology"},{"issue":"6","key":"934_CR14","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1586\/17512433.2016.1157468","volume":"9","author":"P Fallahi","year":"2016","unstructured":"Fallahi, P., S.M. Ferrari, G. Elia, F. Nasini, M. Colaci, D. Giuggioli, R. Vita, S. Benvenga, C. Ferri, and A. Antonelli. 2016. Novel therapies for thyroid autoimmune diseases. Expert Review of Clinical Pharmacology 9 (6): 853\u2013861.","journal-title":"Expert Review of Clinical Pharmacology"},{"issue":"3","key":"934_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","volume":"13","author":"A Antonelli","year":"2014","unstructured":"Antonelli, A., S.M. Ferrari, D. Giuggioli, E. Ferrannini, C. Ferri, and P. Fallahi. 2014. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmunity Reviews 13 (3): 272\u2013280.","journal-title":"Autoimmunity Reviews"},{"issue":"1","key":"934_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cytogfr.2014.01.006","volume":"25","author":"A Antonelli","year":"2014","unstructured":"Antonelli, A., S.M. Ferrari, A. Corrado, E. Ferrannini, and P. Fallahi. 2014. CXCR3, CXCL10 and type 1 diabetes. Cytokine & Growth Factor Reviews 25 (1): 57\u201365.","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"2","key":"934_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.advms.2015.07.011","volume":"60","author":"SM Ferrari","year":"2015","unstructured":"Ferrari, S.M., I. Ruffilli, M. Colaci, A. Antonelli, C. Ferri, and P. Fallahi. 2015. CXCL10 in psoriasis. Advances in Medical Sciences 60 (2): 349\u2013354.","journal-title":"Advances in Medical Sciences"},{"issue":"9","key":"934_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1034\/j.1600-0714.2003.00125.x","volume":"32","author":"EH Meij van der","year":"2003","unstructured":"van der Meij, E.H., and I. van der Waal. 2003. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. Journal of Oral Pathology & Medicine 32 (9): 507\u2013512.","journal-title":"Journal of Oral Pathology & Medicine"},{"issue":"10","key":"934_CR19","doi-asserted-by":"publisher","first-page":"e024083","DOI":"10.1136\/bmjopen-2018-024083","volume":"8","author":"EP Ferri","year":"2018","unstructured":"Ferri, E.P., C.B. Gallo, C.S. Abboud, W.H. Yanaguizawa, A. Horliana, D. Silva, C. Pavani, S.K. Bussadori, F.D. Nunes, R.A. Mesquita-Ferrari, K.P.S. Fernandes, and M.F.S.D. Rodrigues. 2018. Efficacy of photobiomodulation on oral lichen planus: A protocol study for a double-blind, randomised controlled clinical trial. BMJ Open 8 (10): e024083.","journal-title":"BMJ Open"},{"issue":"1","key":"934_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cyto.2013.01.020","volume":"62","author":"JY Hu","year":"2013","unstructured":"Hu, J.Y., J. Zhang, J.L. Cui, X.Y. Liang, R. Lu, G.F. Du, X.Y. Xu, and G. Zhou. 2013. Increasing CCL5\/CCR5 on CD4+ T cells in peripheral blood of oral lichen planus. Cytokine 62 (1): 141\u2013145.","journal-title":"Cytokine"},{"issue":"2","key":"934_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/modpathol.2009.160","volume":"23","author":"LK Liu","year":"2010","unstructured":"Liu, L.K., X.Y. Jiang, X.X. Zhou, D.M. Wang, X.L. Song, and H.B. Jiang. 2010. Upregulation of vimentin and aberrant expression of E-cadherin\/beta-catenin complex in oral squamous cell carcinomas: Correlation with the clinicopathological features and patient outcome. Modern Pathology 23 (2): 213\u2013224.","journal-title":"Modern Pathology"},{"key":"934_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mehy.2017.05.021","volume":"104","author":"P Chaiyarit","year":"2017","unstructured":"Chaiyarit, P., K. Luengtrakoon, W. Wannakasemsuk, V. Vichitrananda, P. Klanrit, D. Hormdee, and R. Noisombut. 2017. Biological functions of melatonin in relation to pathogenesis of oral lichen planus. Medical Hypotheses 104: 40\u201344.","journal-title":"Medical Hypotheses"},{"issue":"4","key":"934_CR23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S","volume":"194","author":"J Flier","year":"2001","unstructured":"Flier, J., D.M. Boorsma, P.J. van Beek, C. Nieboer, T.J. Stoof, R. Willemze, and C.P. Tensen. 2001. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. The Journal of Pathology 194 (4): 398\u2013405.","journal-title":"The Journal of Pathology"},{"issue":"3","key":"934_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1365-2249.2007.03377.x","volume":"148","author":"A Aggarwal","year":"2007","unstructured":"Aggarwal, A., S. Agarwal, and R. Misra. 2007. Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10\/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA). Clinical and Experimental Immunology 148 (3): 515\u2013519.","journal-title":"Clinical and Experimental Immunology"},{"key":"934_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.biopha.2016.04.069","volume":"82","author":"H Zhou","year":"2016","unstructured":"Zhou, H., J. Wu, T. Wang, X. Zhang, and D. Liu. 2016. CXCL10\/CXCR3 axis promotes the invasion of gastric cancer via PI3K\/AKT pathway-dependent MMPs production. Biomedicine & Pharmacotherapy 82: 479\u2013488.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"7","key":"934_CR26","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.2337\/db12-1370","volume":"62","author":"KT Coppieters","year":"2013","unstructured":"Coppieters, K.T., N. Amirian, P.P. Pagni, C. Baca Jones, A. Wiberg, S. Lasch, E. Hintermann, U. Christen, and M.G. von Herrath. 2013. Functional redundancy of CXCR3\/CXCL10 signaling in the recruitment of diabetogenic cytotoxic T lymphocytes to pancreatic islets in a virally induced autoimmune diabetes model. Diabetes 62 (7): 2492\u20132499.","journal-title":"Diabetes"},{"issue":"6","key":"934_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.pediatrneurol.2013.07.019","volume":"49","author":"I Mirones","year":"2013","unstructured":"Mirones, I., I. de Prada, A.M. Gomez, A. Luque, R. Martin, M.A. Perez-Jimenez, L. Madero, J. Garcia-Castro, and M. Ramirez. 2013. A role for the CXCR3\/CXCL10 axis in Rasmussen encephalitis. Pediatric Neurology 49 (6): 451\u2013457 e451.","journal-title":"Pediatric Neurology"},{"issue":"5","key":"934_CR28","doi-asserted-by":"publisher","first-page":"R241","DOI":"10.1186\/ar783","volume":"5","author":"P Ruschpler","year":"2003","unstructured":"Ruschpler, P., P. Lorenz, W. Eichler, D. Koczan, C. Hanel, R. Scholz, C. Melzer, H.J. Thiesen, and P. Stiehl. 2003. High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis Research & Therapy 5 (5): R241\u2013R252.","journal-title":"Arthritis Research & Therapy"},{"issue":"6","key":"934_CR29","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00415-002-0699-z","volume":"249","author":"N Teleshova","year":"2002","unstructured":"Teleshova, N., M. Pashenkov, Y.M. Huang, M. Soderstrom, P. Kivisakk, V. Kostulas, M. Haglund, and H. Link. 2002. Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid. Journal of Neurology 249 (6): 723\u2013729.","journal-title":"Journal of Neurology"},{"issue":"3","key":"934_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pjnns.2016.02.003","volume":"50","author":"I Jatczak-Pawlik","year":"2016","unstructured":"Jatczak-Pawlik, I., D. Ksiazek-Winiarek, D. Wojkowska, K. Jozwiak, K. Jastrzebski, M. Pietruczuk, and A. Glabinski. 2016. The impact of multiple sclerosis relapse treatment on migration of effector T cells\u2014preliminary study. Neurologia i Neurochirurgia Polska 50 (3): 155\u2013162.","journal-title":"Neurologia i Neurochirurgia Polska"},{"issue":"10","key":"934_CR31","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.4049\/jimmunol.176.10.6235","volume":"176","author":"MW Cruise","year":"2006","unstructured":"Cruise, M.W., J.R. Lukens, A.P. Nguyen, M.G. Lassen, S.N. Waggoner, and Y.S. Hahn. 2006. Fas ligand is responsible for CXCR3 chemokine induction in CD4+ T cell-dependent liver damage. Journal of Immunology 176 (10): 6235\u20136244.","journal-title":"Journal of Immunology"},{"issue":"2","key":"934_CR32","doi-asserted-by":"publisher","first-page":"e89068","DOI":"10.1371\/journal.pone.0089068","volume":"9","author":"C Bondar","year":"2014","unstructured":"Bondar, C., R.E. Araya, L. Guzman, E.C. Rua, N. Chopita, and F.G. Chirdo. 2014. Role of CXCR3\/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease. PLoS One 9 (2): e89068.","journal-title":"PLoS One"},{"issue":"2","key":"934_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1900\/RDS.2009.6.81","volume":"6","author":"A Shimada","year":"2009","unstructured":"Shimada, A., Y. Oikawa, Y. Yamada, Y. Okubo, and S. Narumi. 2009. The role of the CXCL10\/CXCR3 system in type 1 diabetes. The Review of Diabetic Studies 6 (2): 81\u201384.","journal-title":"The Review of Diabetic Studies"},{"issue":"2","key":"934_CR34","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ajpath.2016.10.009","volume":"187","author":"Y Ha","year":"2017","unstructured":"Ha, Y., H. Liu, S. Zhu, P. Yi, W. Liu, J. Nathanson, R. Kayed, B. Loucas, J. Sun, L.J. Frishman, M. Motamedi, and W. Zhang. 2017. Critical role of the CXCL10\/C-X-C chemokine receptor 3 axis in promoting leukocyte recruitment and neuronal injury during traumatic optic neuropathy induced by optic nerve crush. The American Journal of Pathology 187 (2): 352\u2013365.","journal-title":"The American Journal of Pathology"},{"issue":"11","key":"934_CR35","first-page":"14542","volume":"8","author":"J He","year":"2015","unstructured":"He, J., C. Lian, Y. Fang, J. Wu, J. Weng, X. Ye, and H. Zhou. 2015. Effect of CXCL10 receptor antagonist on islet cell apoptosis in a type I diabetes rat model. International Journal of Clinical and Experimental Pathology 8 (11): 14542\u201314548.","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"2","key":"934_CR36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cyto.2012.05.002","volume":"59","author":"AM Sidahmed","year":"2012","unstructured":"Sidahmed, A.M., A.J. Leon, S.E. Bosinger, D. Banner, A. Danesh, M.J. Cameron, and D.J. Kelvin. 2012. CXCL10 contributes to p38-mediated apoptosis in primary T lymphocytes in vitro. Cytokine 59 (2): 433\u2013441.","journal-title":"Cytokine"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-018-0934-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-018-0934-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-018-0934-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T19:18:48Z","timestamp":1574363928000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-018-0934-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,22]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1007\/s10753-018-0934-0","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,22]]},"assertion":[{"value":"22 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All experiments were informed consent by participants and approved by the Ethics Committee of Nanjing Medical University, Nanjing, China. (2014-132)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}